US – Royal DSM, a global science-based leader in health, nutrition and bioscience, has started acquisition talks with Adare Pharma Solutions to buy Adare Biome, a pioneer in the development and manufacturing of postbiotics, for an enterprise value of US$301.2 million.
DSM anticipates the rapid extension of the availability of Adare Biome’s Lactéol for people through its B2C unit, i-Health.
“DSM would be the ideal company to take Adare Biome to a new level and realize the growth potential of postbiotics,” Tom Selling, CEO of Andare Pharma Solutions said.
“They have the infrastructure and strong commercialization and science capabilities to scale the significant scientific research achieved over the years and DSM’s mission to create healthier lives for all will resonate strongly with the team.”
Additionally, further development of the postbiotic B2B ingredient will include science development and developing opportunities in dietary supplements, early life nutrition, medical nutrition, and nutritional improvement for the under-nourished.
“Adare Biome would be a perfect fit for DSM, with pioneering science that will complement each of our three businesses,” Philip Eykerman, DSM’s Executive Vice President of Health, Nutrition & Care, added.
“The Adare Biome team will greatly help in accelerating our ‘health from the gut’ strategy as there is considerable untapped potential for next-generation biotics to support the health of people and animals.”
Adare Biome would also help establish DSM as a frontrunner in the growing microbiome management market for pets and expand its animal health range; the stability of postbiotics means they can be incorporated into DSM’s premix feed solutions.
Postbiotics are a rapidly emerging segment of the gut health market that is projected to reach US $24.03 million by 2029, at a CAGR of 10.1% during the forecast period 2022-2029 by GlobalNewswire.
Unlike the live bacteria in probiotics, postbiotics consist of inanimate microorganisms and/or their cellular components and metabolites that confer a health benefit to the host.
A growing body of scientific evidence shows that postbiotics deliver comparable health benefits and are more stable so have a longer shelf-life and can be used in a wider range of applications and new ingredient combinations.
Royal DSM has also partnered with Partners in Food Solutions, an independent nonprofit organization, that is working to strengthen food security, improve nutrition and increase economic development across Africa.
The organization works by expanding and increasing the competitiveness of the food processing sector.
They link corporate volunteers from their consortium of world-class food companies with promising entrepreneurs in twelve African countries.
For all the latest food industry news from Africa and the World, subscribe to our NEWSLETTER, follow us on Twitter and LinkedIn, like us on Facebook and subscribe to our YouTube channel.